Hi Gaurav,
I do not think much about the tax raid, there are many examples of this and nothing comes out, like Avanti faced big raids in 2019 etc. Lock-in ending is not so bad phase also, looking at the shareholding structure, mostly MFs may book-losses, on the other hand ICICI pharma fund has doubled initial stake. I too have been buying but run out of cash and position size got too big.
Fundamentally results are not that bad, when asked before I had answered that Q3 FY22 figures were the base for my decision, that will be easily beaten. Stock is on cheaper side given potential for hockey stick growth. Granted that management may not be seasoned enough to give better projections.
The PPP space in healthcare has good growth forecasts, and Krsnaa is trying and is leader in its domain. Enough to have some patience for now.
| Subscribe To Our Free Newsletter |
